Mark Nehler
Concepts (413)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peripheral Arterial Disease | 34 | 2026 | 507 | 4.210 |
Why?
| | Ischemia | 30 | 2024 | 421 | 3.790 |
Why?
| | Lower Extremity | 23 | 2026 | 453 | 2.390 |
Why?
| | Internship and Residency | 19 | 2026 | 1281 | 2.310 |
Why?
| | Rivaroxaban | 21 | 2026 | 270 | 2.180 |
Why?
| | Vascular Surgical Procedures | 26 | 2026 | 352 | 2.150 |
Why?
| | General Surgery | 12 | 2026 | 217 | 2.110 |
Why?
| | Endovascular Procedures | 12 | 2026 | 390 | 1.590 |
Why?
| | Platelet Aggregation Inhibitors | 19 | 2026 | 499 | 1.530 |
Why?
| | Leg | 14 | 2007 | 246 | 1.360 |
Why?
| | Aspirin | 17 | 2026 | 405 | 1.330 |
Why?
| | Factor Xa Inhibitors | 11 | 2026 | 195 | 1.310 |
Why?
| | Peripheral Vascular Diseases | 12 | 2022 | 102 | 1.240 |
Why?
| | Limb Salvage | 11 | 2026 | 74 | 0.980 |
Why?
| | Blood Vessel Prosthesis Implantation | 6 | 2023 | 219 | 0.930 |
Why?
| | Surgeons | 4 | 2021 | 351 | 0.790 |
Why?
| | Femoral Artery | 10 | 2023 | 183 | 0.770 |
Why?
| | Vascular System Injuries | 5 | 2025 | 79 | 0.760 |
Why?
| | Education, Medical, Graduate | 7 | 2026 | 568 | 0.740 |
Why?
| | Arterial Occlusive Diseases | 7 | 2008 | 88 | 0.740 |
Why?
| | Thrombosis | 6 | 2025 | 398 | 0.730 |
Why?
| | Treatment Outcome | 48 | 2026 | 11821 | 0.720 |
Why?
| | Risk Factors | 37 | 2026 | 10921 | 0.640 |
Why?
| | Aortic Aneurysm, Abdominal | 3 | 2017 | 164 | 0.630 |
Why?
| | Career Choice | 4 | 2024 | 237 | 0.630 |
Why?
| | Popliteal Artery | 7 | 2023 | 60 | 0.630 |
Why?
| | Intermittent Claudication | 12 | 2022 | 121 | 0.620 |
Why?
| | Puerperal Disorders | 1 | 2020 | 35 | 0.610 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2020 | 83 | 0.600 |
Why?
| | Venous Thromboembolism | 4 | 2025 | 332 | 0.570 |
Why?
| | Personnel Selection | 3 | 2018 | 90 | 0.560 |
Why?
| | Vascular Patency | 13 | 2023 | 115 | 0.540 |
Why?
| | Time Factors | 22 | 2026 | 7109 | 0.540 |
Why?
| | Aged | 52 | 2026 | 26432 | 0.530 |
Why?
| | Humans | 121 | 2026 | 146342 | 0.530 |
Why?
| | Postoperative Complications | 12 | 2024 | 3034 | 0.520 |
Why?
| | Male | 78 | 2026 | 73396 | 0.510 |
Why?
| | Risk Assessment | 16 | 2025 | 3712 | 0.500 |
Why?
| | Coronary Artery Disease | 5 | 2024 | 751 | 0.490 |
Why?
| | Female | 73 | 2026 | 79499 | 0.480 |
Why?
| | Quality Indicators, Health Care | 3 | 2016 | 343 | 0.460 |
Why?
| | Elective Surgical Procedures | 2 | 2017 | 216 | 0.450 |
Why?
| | Middle Aged | 53 | 2026 | 36619 | 0.440 |
Why?
| | Mentors | 2 | 2020 | 217 | 0.440 |
Why?
| | Clinical Competence | 4 | 2022 | 1272 | 0.430 |
Why?
| | Arteriovenous Shunt, Surgical | 2 | 2011 | 21 | 0.400 |
Why?
| | Incidence | 11 | 2025 | 2936 | 0.390 |
Why?
| | Angioplasty, Balloon | 3 | 2023 | 92 | 0.380 |
Why?
| | Renal Dialysis | 3 | 2013 | 461 | 0.370 |
Why?
| | Aged, 80 and over | 23 | 2026 | 8391 | 0.370 |
Why?
| | Upper Extremity | 2 | 2011 | 114 | 0.370 |
Why?
| | Drug Therapy, Combination | 10 | 2026 | 1036 | 0.360 |
Why?
| | Retrospective Studies | 28 | 2025 | 17438 | 0.360 |
Why?
| | Paclitaxel | 3 | 2021 | 260 | 0.360 |
Why?
| | Patient Care Management | 1 | 2011 | 54 | 0.330 |
Why?
| | Kidney Failure, Chronic | 4 | 2013 | 589 | 0.320 |
Why?
| | Alprostadil | 2 | 2007 | 29 | 0.310 |
Why?
| | Medicaid | 1 | 2014 | 477 | 0.300 |
Why?
| | Activities of Daily Living | 4 | 2006 | 442 | 0.300 |
Why?
| | Adult | 35 | 2026 | 41087 | 0.290 |
Why?
| | Quality of Life | 6 | 2022 | 3200 | 0.290 |
Why?
| | Wound Healing | 5 | 2009 | 354 | 0.280 |
Why?
| | Patient Readmission | 5 | 2023 | 778 | 0.280 |
Why?
| | Continuity of Patient Care | 1 | 2011 | 298 | 0.280 |
Why?
| | United States | 18 | 2025 | 16136 | 0.270 |
Why?
| | Curriculum | 6 | 2026 | 1079 | 0.270 |
Why?
| | Drug-Eluting Stents | 2 | 2021 | 88 | 0.270 |
Why?
| | Brain Ischemia | 2 | 2022 | 362 | 0.270 |
Why?
| | Medicare | 1 | 2014 | 920 | 0.270 |
Why?
| | Double-Blind Method | 10 | 2026 | 2070 | 0.260 |
Why?
| | Kidney Diseases | 2 | 2011 | 428 | 0.260 |
Why?
| | Comorbidity | 7 | 2017 | 1665 | 0.260 |
Why?
| | Ribs | 2 | 2016 | 35 | 0.250 |
Why?
| | Students, Medical | 2 | 2023 | 383 | 0.250 |
Why?
| | Hemorrhage | 8 | 2026 | 825 | 0.250 |
Why?
| | Computer Simulation | 1 | 2011 | 1014 | 0.240 |
Why?
| | Prodrugs | 1 | 2007 | 54 | 0.240 |
Why?
| | Decision Support Techniques | 2 | 2021 | 478 | 0.240 |
Why?
| | Stroke | 3 | 2022 | 1287 | 0.240 |
Why?
| | Surveys and Questionnaires | 10 | 2024 | 6073 | 0.240 |
Why?
| | Critical Illness | 6 | 2020 | 908 | 0.230 |
Why?
| | Myocardial Infarction | 3 | 2022 | 1215 | 0.230 |
Why?
| | Thoracic Outlet Syndrome | 2 | 2016 | 14 | 0.230 |
Why?
| | Atherosclerosis | 2 | 2020 | 410 | 0.230 |
Why?
| | Software | 1 | 2011 | 676 | 0.230 |
Why?
| | Venous Thrombosis | 2 | 2025 | 199 | 0.230 |
Why?
| | Anticoagulants | 5 | 2025 | 746 | 0.220 |
Why?
| | Neoplasms | 1 | 2021 | 2954 | 0.220 |
Why?
| | Catheterization, Peripheral | 2 | 2009 | 116 | 0.220 |
Why?
| | Stress, Psychological | 2 | 2026 | 1171 | 0.220 |
Why?
| | Graft Occlusion, Vascular | 3 | 2011 | 39 | 0.210 |
Why?
| | Femoral Vein | 3 | 2008 | 36 | 0.210 |
Why?
| | Cardiovascular Surgical Procedures | 2 | 2001 | 31 | 0.210 |
Why?
| | Professional-Family Relations | 1 | 2026 | 158 | 0.210 |
Why?
| | Iliac Aneurysm | 2 | 2022 | 17 | 0.210 |
Why?
| | Attitude of Health Personnel | 3 | 2024 | 1219 | 0.210 |
Why?
| | Reoperation | 10 | 2014 | 645 | 0.210 |
Why?
| | Parental Leave | 1 | 2024 | 27 | 0.200 |
Why?
| | Carotid Stenosis | 2 | 1996 | 103 | 0.200 |
Why?
| | Chi-Square Distribution | 3 | 2017 | 517 | 0.200 |
Why?
| | Urology | 1 | 2024 | 63 | 0.200 |
Why?
| | Ultrasonography, Doppler | 2 | 2021 | 122 | 0.200 |
Why?
| | Fibrinolytic Agents | 3 | 2022 | 303 | 0.190 |
Why?
| | Acute Disease | 4 | 2021 | 1038 | 0.190 |
Why?
| | Diabetes Complications | 3 | 2015 | 219 | 0.190 |
Why?
| | Cranial Nerve Injuries | 1 | 2023 | 4 | 0.190 |
Why?
| | Patient Care Team | 2 | 2024 | 701 | 0.190 |
Why?
| | Carotid Body Tumor | 1 | 2023 | 5 | 0.190 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2023 | 92 | 0.190 |
Why?
| | Diabetic Foot | 2 | 2019 | 25 | 0.180 |
Why?
| | Academic Medical Centers | 3 | 2017 | 561 | 0.180 |
Why?
| | Pulmonary Embolism | 1 | 2025 | 246 | 0.180 |
Why?
| | Cholesterol, LDL | 1 | 2024 | 363 | 0.180 |
Why?
| | Meditation | 1 | 2022 | 34 | 0.180 |
Why?
| | Antifibrinolytic Agents | 1 | 2023 | 68 | 0.180 |
Why?
| | Tibial Arteries | 4 | 2008 | 14 | 0.180 |
Why?
| | Thrombolytic Therapy | 1 | 2003 | 165 | 0.170 |
Why?
| | Smoking Cessation | 2 | 2002 | 442 | 0.170 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2023 | 135 | 0.170 |
Why?
| | Blood Vessel Prosthesis | 3 | 2022 | 133 | 0.170 |
Why?
| | Blood Coagulation Disorders | 1 | 2023 | 190 | 0.160 |
Why?
| | Heparin | 3 | 2023 | 247 | 0.160 |
Why?
| | Faculty, Medical | 1 | 2024 | 309 | 0.160 |
Why?
| | Hemostatic Techniques | 1 | 2001 | 50 | 0.160 |
Why?
| | Hospital Departments | 1 | 2020 | 9 | 0.160 |
Why?
| | Outpatients | 1 | 2024 | 440 | 0.160 |
Why?
| | Aortic Diseases | 1 | 2001 | 125 | 0.160 |
Why?
| | Specialties, Surgical | 2 | 2017 | 88 | 0.160 |
Why?
| | Suture Techniques | 1 | 2001 | 138 | 0.150 |
Why?
| | Quality Improvement | 2 | 2022 | 1354 | 0.150 |
Why?
| | Blood Pressure Determination | 1 | 2021 | 143 | 0.150 |
Why?
| | Hyperlipidemias | 1 | 2001 | 120 | 0.150 |
Why?
| | Forefoot, Human | 1 | 1999 | 1 | 0.150 |
Why?
| | Multivariate Analysis | 4 | 2019 | 1543 | 0.150 |
Why?
| | Toes | 1 | 1999 | 16 | 0.150 |
Why?
| | Mentoring | 1 | 2022 | 166 | 0.150 |
Why?
| | Communication | 1 | 2026 | 980 | 0.150 |
Why?
| | Burnout, Professional | 2 | 2026 | 493 | 0.150 |
Why?
| | Logistic Models | 3 | 2017 | 2126 | 0.150 |
Why?
| | Aneurysm | 2 | 1997 | 37 | 0.150 |
Why?
| | Canagliflozin | 1 | 2019 | 11 | 0.150 |
Why?
| | Proportional Hazards Models | 3 | 2021 | 1331 | 0.140 |
Why?
| | Self Concept | 1 | 2021 | 257 | 0.140 |
Why?
| | Counseling | 1 | 2002 | 406 | 0.140 |
Why?
| | Databases, Factual | 4 | 2017 | 1493 | 0.140 |
Why?
| | Walking | 4 | 2022 | 546 | 0.140 |
Why?
| | Clinical Clerkship | 1 | 2020 | 111 | 0.140 |
Why?
| | Patient Selection | 4 | 2014 | 728 | 0.140 |
Why?
| | Chronic Disease | 6 | 2011 | 1827 | 0.140 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 70 | 0.140 |
Why?
| | Drug Prescriptions | 1 | 2020 | 314 | 0.140 |
Why?
| | Blood Vessels | 2 | 1998 | 164 | 0.140 |
Why?
| | Iatrogenic Disease | 1 | 1998 | 74 | 0.130 |
Why?
| | Extremities | 2 | 2009 | 142 | 0.130 |
Why?
| | School Admission Criteria | 1 | 2018 | 35 | 0.130 |
Why?
| | Arm | 2 | 2004 | 111 | 0.130 |
Why?
| | Odds Ratio | 3 | 2016 | 1077 | 0.130 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2024 | 1763 | 0.130 |
Why?
| | Cardiovascular Diseases | 5 | 2024 | 2219 | 0.130 |
Why?
| | Arteriosclerosis | 1 | 1997 | 82 | 0.130 |
Why?
| | Physician Executives | 1 | 2017 | 29 | 0.130 |
Why?
| | Ultrasonography, Doppler, Duplex | 2 | 1996 | 39 | 0.130 |
Why?
| | Exercise Therapy | 2 | 2001 | 488 | 0.130 |
Why?
| | Follow-Up Studies | 9 | 2021 | 5439 | 0.130 |
Why?
| | Cost of Illness | 1 | 2019 | 323 | 0.130 |
Why?
| | Homocysteine | 1 | 1997 | 152 | 0.130 |
Why?
| | Subclavian Artery | 1 | 1997 | 28 | 0.130 |
Why?
| | Vascular Diseases | 2 | 2015 | 252 | 0.130 |
Why?
| | Diabetes Mellitus | 3 | 2021 | 1101 | 0.120 |
Why?
| | Military Personnel | 1 | 2025 | 726 | 0.120 |
Why?
| | Hospitalization | 2 | 2025 | 2475 | 0.120 |
Why?
| | Tertiary Care Centers | 1 | 2017 | 196 | 0.120 |
Why?
| | Incidental Findings | 1 | 2016 | 81 | 0.120 |
Why?
| | Vascular Malformations | 1 | 2016 | 53 | 0.120 |
Why?
| | Endarterectomy, Carotid | 2 | 2013 | 63 | 0.110 |
Why?
| | Sepsis | 2 | 2016 | 669 | 0.110 |
Why?
| | Osteotomy | 1 | 2016 | 138 | 0.110 |
Why?
| | Survival Rate | 4 | 2021 | 2092 | 0.110 |
Why?
| | Interprofessional Relations | 1 | 2017 | 275 | 0.110 |
Why?
| | Popliteal Vein | 1 | 1994 | 5 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 4 | 2021 | 970 | 0.110 |
Why?
| | Hypertension | 2 | 2001 | 1272 | 0.110 |
Why?
| | Multidetector Computed Tomography | 1 | 2014 | 40 | 0.100 |
Why?
| | Disease Progression | 3 | 2014 | 2867 | 0.100 |
Why?
| | Endarterectomy | 1 | 1993 | 5 | 0.100 |
Why?
| | Thoracotomy | 1 | 2014 | 87 | 0.100 |
Why?
| | Premedication | 1 | 1993 | 45 | 0.100 |
Why?
| | Bandages | 1 | 1993 | 38 | 0.100 |
Why?
| | Registries | 4 | 2025 | 2400 | 0.100 |
Why?
| | Multiple Trauma | 1 | 2014 | 118 | 0.100 |
Why?
| | Surgery, Computer-Assisted | 1 | 2014 | 87 | 0.100 |
Why?
| | Young Adult | 7 | 2025 | 14330 | 0.100 |
Why?
| | Recurrence | 4 | 2014 | 1133 | 0.100 |
Why?
| | Program Evaluation | 1 | 2017 | 952 | 0.090 |
Why?
| | Ulnar Artery | 1 | 1992 | 4 | 0.090 |
Why?
| | Recovery of Function | 3 | 2011 | 725 | 0.090 |
Why?
| | Injury Severity Score | 3 | 2021 | 572 | 0.090 |
Why?
| | Ischemic Attack, Transient | 1 | 1993 | 71 | 0.090 |
Why?
| | Research Design | 2 | 2009 | 1143 | 0.090 |
Why?
| | Life Tables | 3 | 1998 | 21 | 0.090 |
Why?
| | Radial Artery | 1 | 1992 | 74 | 0.090 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2021 | 1408 | 0.090 |
Why?
| | Renal Insufficiency | 1 | 2014 | 173 | 0.090 |
Why?
| | Fingers | 1 | 1992 | 106 | 0.090 |
Why?
| | Predictive Value of Tests | 4 | 2021 | 2113 | 0.090 |
Why?
| | Seasons | 1 | 2014 | 540 | 0.090 |
Why?
| | Angiography | 2 | 2024 | 206 | 0.090 |
Why?
| | Adolescent | 8 | 2025 | 22557 | 0.090 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 1221 | 0.090 |
Why?
| | Research Personnel | 1 | 2013 | 190 | 0.090 |
Why?
| | Oregon | 1 | 2011 | 83 | 0.080 |
Why?
| | Thrombectomy | 2 | 2003 | 79 | 0.080 |
Why?
| | Aorta, Thoracic | 1 | 2014 | 284 | 0.080 |
Why?
| | Pregnancy | 2 | 2024 | 7230 | 0.080 |
Why?
| | Prognosis | 5 | 2021 | 4351 | 0.080 |
Why?
| | Efficiency | 1 | 2011 | 102 | 0.080 |
Why?
| | Arteries | 2 | 2022 | 261 | 0.080 |
Why?
| | Catheterization | 2 | 2003 | 179 | 0.080 |
Why?
| | Controlled Clinical Trials as Topic | 1 | 2009 | 26 | 0.080 |
Why?
| | Device Approval | 1 | 2009 | 19 | 0.080 |
Why?
| | Reproducibility of Results | 3 | 2021 | 3416 | 0.080 |
Why?
| | Fellowships and Scholarships | 1 | 2013 | 355 | 0.070 |
Why?
| | Disability Evaluation | 1 | 2011 | 297 | 0.070 |
Why?
| | Risk Management | 3 | 2007 | 81 | 0.070 |
Why?
| | Workload | 1 | 2011 | 170 | 0.070 |
Why?
| | Hypoglycemic Agents | 1 | 2019 | 1412 | 0.070 |
Why?
| | Coated Materials, Biocompatible | 2 | 2023 | 64 | 0.070 |
Why?
| | Safety | 1 | 2011 | 347 | 0.070 |
Why?
| | Axillary Vein | 1 | 2008 | 5 | 0.070 |
Why?
| | Skin | 1 | 1993 | 701 | 0.070 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2024 | 449 | 0.070 |
Why?
| | Saphenous Vein | 3 | 1998 | 36 | 0.070 |
Why?
| | Global Health | 2 | 2021 | 403 | 0.070 |
Why?
| | Radiography | 4 | 2015 | 861 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2021 | 2022 | 0.070 |
Why?
| | Athletic Injuries | 1 | 2014 | 575 | 0.060 |
Why?
| | Antineoplastic Agents, Phytogenic | 2 | 2021 | 178 | 0.060 |
Why?
| | Family Practice | 2 | 2020 | 422 | 0.060 |
Why?
| | Colorado | 3 | 2016 | 4595 | 0.060 |
Why?
| | Practice Guidelines as Topic | 2 | 2011 | 1591 | 0.060 |
Why?
| | Brachial Artery | 1 | 2008 | 207 | 0.060 |
Why?
| | Prevalence | 1 | 2014 | 2861 | 0.060 |
Why?
| | Biomedical Research | 1 | 2013 | 729 | 0.060 |
Why?
| | Iloprost | 1 | 2006 | 45 | 0.060 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2007 | 429 | 0.060 |
Why?
| | Exercise Test | 3 | 2011 | 637 | 0.050 |
Why?
| | Carotid Artery, Internal | 2 | 1996 | 45 | 0.050 |
Why?
| | Prospective Studies | 5 | 2021 | 8123 | 0.050 |
Why?
| | United States Department of Defense | 1 | 2025 | 26 | 0.050 |
Why?
| | Regional Blood Flow | 2 | 1999 | 507 | 0.050 |
Why?
| | Sulfonic Acids | 1 | 2004 | 14 | 0.050 |
Why?
| | United States Department of Veterans Affairs | 1 | 2009 | 777 | 0.050 |
Why?
| | Thrombophilia | 1 | 2025 | 89 | 0.050 |
Why?
| | Acetates | 1 | 2004 | 78 | 0.050 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2019 | 2623 | 0.050 |
Why?
| | Single-Blind Method | 2 | 2015 | 313 | 0.050 |
Why?
| | Veins | 2 | 1995 | 68 | 0.050 |
Why?
| | Specialty Boards | 1 | 2024 | 42 | 0.050 |
Why?
| | Blood Pressure | 2 | 2021 | 1765 | 0.050 |
Why?
| | Thromboplastin | 1 | 2023 | 67 | 0.050 |
Why?
| | Physical Exertion | 1 | 2004 | 204 | 0.050 |
Why?
| | Atherectomy | 1 | 2023 | 37 | 0.050 |
Why?
| | Forecasting | 2 | 2001 | 388 | 0.050 |
Why?
| | Clinical Trials as Topic | 1 | 2008 | 1064 | 0.050 |
Why?
| | Survival Analysis | 2 | 2004 | 1378 | 0.050 |
Why?
| | Diagnostic Techniques, Cardiovascular | 1 | 2002 | 16 | 0.050 |
Why?
| | Sexism | 1 | 2023 | 70 | 0.050 |
Why?
| | Preoperative Care | 2 | 2002 | 396 | 0.040 |
Why?
| | Numbers Needed To Treat | 1 | 2021 | 7 | 0.040 |
Why?
| | Morbidity | 1 | 2023 | 319 | 0.040 |
Why?
| | Off-Label Use | 1 | 2022 | 50 | 0.040 |
Why?
| | Mobility Limitation | 1 | 2022 | 68 | 0.040 |
Why?
| | Psychomotor Performance | 1 | 2004 | 329 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2025 | 486 | 0.040 |
Why?
| | Societies, Medical | 2 | 2009 | 907 | 0.040 |
Why?
| | Hemangioendothelioma, Epithelioid | 1 | 2001 | 7 | 0.040 |
Why?
| | Vascular Neoplasms | 1 | 2001 | 19 | 0.040 |
Why?
| | Cadaver | 1 | 2022 | 304 | 0.040 |
Why?
| | Angioplasty | 1 | 2001 | 49 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 823 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2004 | 721 | 0.040 |
Why?
| | Frailty | 1 | 2024 | 208 | 0.040 |
Why?
| | Aneurysm, False | 1 | 2001 | 46 | 0.040 |
Why?
| | Mass Screening | 1 | 2009 | 1307 | 0.040 |
Why?
| | Equipment Failure | 1 | 2001 | 112 | 0.040 |
Why?
| | Tetrazoles | 1 | 2001 | 50 | 0.040 |
Why?
| | Habits | 1 | 2020 | 47 | 0.040 |
Why?
| | Tissue Plasminogen Activator | 1 | 2022 | 245 | 0.040 |
Why?
| | Heart Failure | 1 | 2014 | 2329 | 0.040 |
Why?
| | Educational Measurement | 1 | 2024 | 331 | 0.040 |
Why?
| | Joint Dislocations | 1 | 2021 | 61 | 0.040 |
Why?
| | Physician's Role | 1 | 2002 | 225 | 0.040 |
Why?
| | Arterial Pressure | 1 | 2021 | 130 | 0.040 |
Why?
| | Empathy | 1 | 2022 | 184 | 0.040 |
Why?
| | Stents | 2 | 2022 | 554 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2008 | 2921 | 0.040 |
Why?
| | Internationality | 1 | 2020 | 156 | 0.040 |
Why?
| | Diagnostic Imaging | 3 | 2007 | 340 | 0.040 |
Why?
| | Radiography, Interventional | 1 | 2001 | 128 | 0.040 |
Why?
| | Toe Joint | 1 | 1999 | 5 | 0.040 |
Why?
| | Prosthesis Design | 1 | 2022 | 358 | 0.040 |
Why?
| | Pulse | 1 | 1999 | 30 | 0.040 |
Why?
| | Knee Injuries | 1 | 2021 | 121 | 0.040 |
Why?
| | Proprotein Convertase 9 | 1 | 2020 | 88 | 0.040 |
Why?
| | Artificial Limbs | 1 | 2003 | 215 | 0.040 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2001 | 228 | 0.040 |
Why?
| | Pulsatile Flow | 1 | 1999 | 62 | 0.040 |
Why?
| | Internal Medicine | 1 | 2002 | 280 | 0.040 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2024 | 438 | 0.040 |
Why?
| | Metatarsal Bones | 1 | 1999 | 22 | 0.040 |
Why?
| | Debridement | 1 | 1999 | 86 | 0.040 |
Why?
| | Patient Education as Topic | 1 | 2024 | 770 | 0.040 |
Why?
| | Myocardial Revascularization | 1 | 2019 | 85 | 0.030 |
Why?
| | Anxiety | 1 | 2026 | 1125 | 0.030 |
Why?
| | Arteriovenous Fistula | 1 | 1998 | 36 | 0.030 |
Why?
| | Catheters, Indwelling | 1 | 1998 | 94 | 0.030 |
Why?
| | Clinical Trials, Phase III as Topic | 1 | 2018 | 116 | 0.030 |
Why?
| | Carotid Arteries | 1 | 2019 | 206 | 0.030 |
Why?
| | Intraoperative Complications | 1 | 1998 | 157 | 0.030 |
Why?
| | Purinergic P2Y Receptor Antagonists | 1 | 2018 | 71 | 0.030 |
Why?
| | Postoperative Care | 1 | 2019 | 301 | 0.030 |
Why?
| | Coronary Disease | 1 | 2000 | 380 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2023 | 779 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2020 | 1271 | 0.030 |
Why?
| | Diagnosis, Differential | 2 | 2014 | 1503 | 0.030 |
Why?
| | Knee Joint | 1 | 2021 | 453 | 0.030 |
Why?
| | Neck | 1 | 1997 | 107 | 0.030 |
Why?
| | Age Factors | 1 | 2004 | 3347 | 0.030 |
Why?
| | Administration, Oral | 1 | 2019 | 872 | 0.030 |
Why?
| | Risk | 1 | 2019 | 920 | 0.030 |
Why?
| | Depression | 1 | 2026 | 1575 | 0.030 |
Why?
| | Multicenter Studies as Topic | 1 | 2018 | 417 | 0.030 |
Why?
| | Blood Loss, Surgical | 1 | 2016 | 117 | 0.030 |
Why?
| | Health Promotion | 1 | 2022 | 786 | 0.030 |
Why?
| | Postoperative Hemorrhage | 1 | 2016 | 106 | 0.030 |
Why?
| | Cardiology | 1 | 2019 | 363 | 0.030 |
Why?
| | Fractures, Bone | 1 | 2021 | 436 | 0.030 |
Why?
| | Aortic Rupture | 1 | 1995 | 28 | 0.030 |
Why?
| | Foot | 1 | 1996 | 109 | 0.030 |
Why?
| | Aorta, Abdominal | 1 | 1995 | 51 | 0.030 |
Why?
| | Pain Measurement | 2 | 2009 | 573 | 0.030 |
Why?
| | Groin | 1 | 1994 | 13 | 0.030 |
Why?
| | Vaccination | 1 | 2023 | 1449 | 0.030 |
Why?
| | Carotid Artery, External | 1 | 1993 | 3 | 0.030 |
Why?
| | Orthopedic Equipment | 1 | 1993 | 5 | 0.030 |
Why?
| | Venous Insufficiency | 1 | 1993 | 12 | 0.020 |
Why?
| | Prosthesis Failure | 1 | 1994 | 126 | 0.020 |
Why?
| | Glasgow Coma Scale | 1 | 2014 | 211 | 0.020 |
Why?
| | Cerebral Revascularization | 1 | 1993 | 22 | 0.020 |
Why?
| | Carotid Artery, Common | 1 | 1993 | 31 | 0.020 |
Why?
| | Operative Time | 1 | 2014 | 195 | 0.020 |
Why?
| | Cerebral Angiography | 1 | 1993 | 121 | 0.020 |
Why?
| | Ankle | 1 | 1993 | 73 | 0.020 |
Why?
| | Arteritis | 1 | 1993 | 23 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 2 | 2016 | 2786 | 0.020 |
Why?
| | Pressure | 1 | 1993 | 221 | 0.020 |
Why?
| | Housing | 1 | 1993 | 142 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2016 | 349 | 0.020 |
Why?
| | Exercise | 1 | 2004 | 2213 | 0.020 |
Why?
| | Longitudinal Studies | 2 | 1999 | 3017 | 0.020 |
Why?
| | Inflammation | 1 | 2023 | 2919 | 0.020 |
Why?
| | Nursing Homes | 1 | 1993 | 171 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1408 | 0.020 |
Why?
| | Cohort Studies | 1 | 2022 | 6077 | 0.020 |
Why?
| | Pain | 2 | 2009 | 790 | 0.020 |
Why?
| | Sickness Impact Profile | 1 | 2011 | 67 | 0.020 |
Why?
| | Lung | 1 | 2004 | 4122 | 0.020 |
Why?
| | Pneumonia | 1 | 2016 | 635 | 0.020 |
Why?
| | Child | 2 | 2020 | 22693 | 0.020 |
Why?
| | Equipment Safety | 1 | 2009 | 38 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5899 | 0.020 |
Why?
| | Ligation | 1 | 2008 | 88 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 1999 | 1942 | 0.020 |
Why?
| | Illinois | 1 | 2008 | 47 | 0.020 |
Why?
| | Tissue and Organ Harvesting | 1 | 2008 | 69 | 0.020 |
Why?
| | Smoking | 1 | 2015 | 1486 | 0.020 |
Why?
| | Equipment Design | 1 | 2009 | 520 | 0.020 |
Why?
| | Length of Stay | 1 | 2014 | 1358 | 0.020 |
Why?
| | Cardiovascular Agents | 1 | 2009 | 165 | 0.020 |
Why?
| | Ulcer | 1 | 2007 | 37 | 0.020 |
Why?
| | Constriction, Pathologic | 1 | 2008 | 240 | 0.020 |
Why?
| | Magnetic Resonance Angiography | 1 | 2009 | 249 | 0.020 |
Why?
| | Cerebral Arterial Diseases | 1 | 2007 | 50 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2009 | 731 | 0.010 |
Why?
| | Drug Carriers | 1 | 2006 | 138 | 0.010 |
Why?
| | Infusions, Intravenous | 1 | 2006 | 432 | 0.010 |
Why?
| | Sterol O-Acyltransferase | 1 | 2004 | 6 | 0.010 |
Why?
| | Acetamides | 1 | 2004 | 42 | 0.010 |
Why?
| | Reference Values | 1 | 2006 | 796 | 0.010 |
Why?
| | Cost-Benefit Analysis | 1 | 2007 | 640 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2006 | 790 | 0.010 |
Why?
| | Hemodynamics | 1 | 2009 | 1114 | 0.010 |
Why?
| | Hyperemia | 1 | 2004 | 49 | 0.010 |
Why?
| | Blood Flow Velocity | 1 | 2004 | 419 | 0.010 |
Why?
| | Ultrasonography | 1 | 2006 | 788 | 0.010 |
Why?
| | Treatment Refusal | 1 | 2002 | 99 | 0.010 |
Why?
| | Lipids | 1 | 2006 | 714 | 0.010 |
Why?
| | World Health Organization | 1 | 2000 | 104 | 0.010 |
Why?
| | Sulfonamides | 1 | 2004 | 594 | 0.010 |
Why?
| | Costs and Cost Analysis | 1 | 2000 | 217 | 0.010 |
Why?
| | Heart Function Tests | 1 | 2000 | 59 | 0.010 |
Why?
| | Algorithms | 1 | 2007 | 1849 | 0.010 |
Why?
| | Epoprostenol | 1 | 1999 | 132 | 0.010 |
Why?
| | Aneurysm, Ruptured | 1 | 1998 | 38 | 0.010 |
Why?
| | Models, Theoretical | 1 | 2000 | 561 | 0.010 |
Why?
| | Gangrene | 1 | 1996 | 11 | 0.010 |
Why?
| | Patient Satisfaction | 1 | 2000 | 706 | 0.010 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 1995 | 37 | 0.010 |
Why?
| | Embolization, Therapeutic | 1 | 1998 | 246 | 0.010 |
Why?
| | Health Status | 1 | 2000 | 827 | 0.010 |
Why?
| | Takayasu Arteritis | 1 | 1993 | 16 | 0.010 |
Why?
| | Behcet Syndrome | 1 | 1993 | 19 | 0.010 |
Why?
| | Infant, Newborn | 1 | 1999 | 6460 | 0.000 |
Why?
|
|
Nehler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|